Kaanders JHAM - Search Results

1

Reirradiation of head and neck cancer: Long-term disease control and toxicity.

Bots WTC, van den Bosch S, Zwijnenburg EM, Dijkema T, van den Broek GB, Weijs WLJ, Verhoef LCG, Kaanders JHAM. Bots WTC, et al. Among authors: kaanders jham. Head Neck. 2017 Jun;39(6):1122-1130. doi: 10.1002/hed.24733. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263446 Free PMC article.

2

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.

Kaanders JH, van Daal WA, Hoogenraad WJ, van der Kogel AJ. Kaanders JH, et al. Int J Radiat Oncol Biol Phys. 1992;24(3):497-503. doi: 10.1016/0360-3016(92)91065-u. Int J Radiat Oncol Biol Phys. 1992. PMID: 1399736

3

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.

Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA. Kaanders JH, et al. Radiother Oncol. 1995 Dec;37(3):190-8. doi: 10.1016/0167-8140(95)01660-0. Radiother Oncol. 1995. PMID: 8746587

4

ARCON: experience in 215 patients with advanced head-and-neck cancer.

Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ. Kaanders JH, et al. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):769-78. doi: 10.1016/s0360-3016(01)02678-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849800 Clinical Trial.

5

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ. Kaanders JH, et al. Cancer Res. 2002 Dec 1;62(23):7066-74. Cancer Res. 2002. PMID: 12460928 Clinical Trial.

6

Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.

Hoogsteen IJ, Pop LA, Marres HA, Merkx MA, van den Hoogen FJ, van der Kogel AJ, Kaanders JH. Hoogsteen IJ, et al. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):83-9. doi: 10.1016/j.ijrobp.2005.07.003. Epub 2005 Oct 5. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213107 Clinical Trial.

7

Cancer recurrence after total laryngectomy: treatment options, survival, and complications.

Ritoe SC, Bergman H, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Ritoe SC, et al. Head Neck. 2006 May;28(5):383-8. doi: 10.1002/hed.20350. Head Neck. 2006. PMID: 16287138

8

The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.

Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH. Jonathan RA, et al. Radiother Oncol. 2006 Jun;79(3):288-97. doi: 10.1016/j.radonc.2006.04.008. Epub 2006 May 26. Radiother Oncol. 2006. PMID: 16730088

9

Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: definition of a high-risk group and estimation of the lead time.

Ritoe SC, Verbeek AL, Krabbe PF, Kaanders JH, van den Hoogen FJ, Marres HA. Ritoe SC, et al. Head Neck. 2007 May;29(5):431-8. doi: 10.1002/hed.20534. Head Neck. 2007. PMID: 17120311

10

Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.

Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ, Kaanders JH. Hoogsteen IJ, et al. Head Neck. 2007 Jun;29(6):591-604. doi: 10.1002/hed.20543. Head Neck. 2007. PMID: 17252597 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters